Delivering transgenic DNA exceeding the carrying capacity of AAV vectors

Methods in Molecular Biology

Volumn 1382, Issue , 2016, Pages 21-39

  Hirsch, Matthew L ^a   Wolf, Sonya J ^a   Samulski, R J ^a  

^a NONE

Author keywords

Adeno associated virus; Concatemer; Fragment; Hybrid; Large gene delivery; Overlapping; Split AAV method; Trans splicing; Vector capacity

Indexed keywords

DNA; PARVOVIRUS VECTOR; PLASMID VECTOR;

DNA END JOINING REPAIR; DNA SYNTHESIS; GENE TARGETING; GENE TRANSFER; GENOMIC FRAGMENT; HOMOLOGOUS RECOMBINATION; NONHUMAN; TRANS SPLICING; TRANSGENE; ADMINISTRATION AND DOSAGE; DEPENDOPARVOVIRUS; DNA PACKAGING; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HEK293 CELL LINE; HUMAN;

DEPENDOVIRUS; DNA PACKAGING; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEK293 CELLS; HUMANS; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 84948784194     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-3271-9_2     Document Type: Chapter

References (41)

1. Hirsch ML, Agbandje-McKenna M, Samulski RJ (2010) Little vector, big gene transduction: fragmented genome reassembly of adenoassociated virus. Mol Ther 18(1):6–8
2. Duan D et al (1999) Formation of adenoassociated virus circular genomes is differentially regulated by adenovirus E4 ORF6 and E2a gene expression. J Virol 73(1):161–169
3. Duan D et al (1998) Circular intermediates of recombinant adeno-associated virus have defi ned structural characteristics responsible for long-term episomal persistence in muscle tissue. J Virol 72(11):8568–8577
4. Duan D, Yue Y, Engelhardt JF (2001) Expanding AAV packaging capacity with transsplicing or overlapping vectors: a quantitative comparison. Mol Ther 4(4):383–391
5. Halbert CL, Allen JM, Miller AD (2002) Effi cient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene. Nat Biotechnol 20(7):697–701
6. Ghosh A et al (2008) A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner. Mol Ther 16(1):124–130
7. Ghosh A et al (2007) Effi cient whole-body transduction with trans-splicing adeno- associated viral vectors. Mol Ther 15(4):750–755
8. Dong B, Nakai H, Xiao W (2010) Characterization of genome integrity for oversized recombinant AAV vector. Mol Ther 18(1):87–92
9. Hirsch ML et al (2013) Oversized AAV transduction is mediated via a DNA-PKcs independent, Rad51C-dependent repair pathway. Mol Ther 21(12):2205–2216
10. Lai Y, Yue Y, Duan D (2010) Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome > or = 8.2 kb. Mol Ther 18(1):75–79
11. Wu Z, Yang H, Colosi P (2010) Effect of genome size on AAV vector packaging. Mol Ther 18(1):80–86
12. Trapani I et al (2014) Effective delivery of large genes to the retina by dual AAV vectors. EMBO Mol Med 6(2):194–211
13. Ghosh A, Yue Y, Duan D (2011) Effi cient transgene reconstitution with hybrid dual AAV vectors carrying the minimized bridging sequences. Hum Gene Ther 22(1):77–83
14. Mitchell AM et al (2010) AAV’s anatomy: roadmap for optimizing vectors for translational success. Curr Gene Ther 10(5): 319–340
15. Samulski RJ et al (1982) Cloning of adenoassociated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci U S A 79(6): 2077–2081
16. Samulski RJ et al (1983) Rescue of adenoassociated virus from recombinant plasmids: gene correction within the terminal repeats of AAV. Cell 33(1):135–143
17. Samulski RJ, Chang LS, Shenk T (1989) Helper-free stocks of recombinant adenoassociated viruses: normal integration does not require viral gene expression. J Virol 63(9): 3822–3828
18. Manno CS et al (2006) Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response. Nat Med 12(3):342–347
19. Testa F et al (2013) Three-year follow-up after unilateral subretinal delivery of adenoassociated virus in patients with Leber congenital Amaurosis type 2. Ophthalmology 120(6): 1283–1291
20. Inagaki K et al (2007) The role of DNA-PKcs and artemis in opening viral DNA hairpin termini in various tissues in mice. J Virol 81(20):11304–11321
21. Choi VW, McCarty DM, Samulski RJ (2006) Host cell DNA repair pathways in adeno- associated viral genome processing. J Virol 80(21):10346–10356
22. Choi VW, Samulski RJ, McCarty DM (2005) Effects of adeno-associated virus DNA hairpin structure on recombination. J Virol 79(11): 6801–6807
23. Sun L, Li J, Xiao X (2000) Overcoming adenoassociated virus vector size limitation through viral DNA heterodimerization. Nat Med 6(5): 599–602
24. Hirsch ML et al (2009) AAV recombineering with single strand oligonucleotides. PLoS One 4(11), e7705
25. Nakai H, Storm TA, Kay MA (2000) Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors. Nat Biotechnol 18(5): 527–532
26. Koo T et al (2014) Triple trans-splicing adenoassociated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice. Hum Gene Ther 25(2):98–108
27. Ghosh A et al (2009) Systemic trans-splicing adeno-associated viral delivery effi ciently transduces the heart of adult mdx mouse, a model Matthew L. Hirsch et al. for Duchenne muscular dystrophy. Hum Gene Ther 20(11):1319–1328
28. Lai Y et al (2008) Design of trans-splicing adeno-associated viral vectors for Duchenne muscular dystrophy gene therapy. Methods Mol Biol 433:259–275
29. Reich SJ et al (2003) Effi cient trans-splicing in the retina expands the utility of adenoassociated virus as a vector for gene therapy. Hum Gene Ther 14(1):37–44
30. Xu Z et al (2004) Trans-splicing adenoassociated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection effi ciency. Hum Gene Ther 15(9):896–905
31. Lai Y et al (2006) Synthetic intron improves transduction effi ciency of trans-splicing adenoassociated viral vectors. Hum Gene Ther 17(10):1036–1042
32. Yang J et al (1999) Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination. J Virol 73(11):9468–9477
33. Zhang Y, Duan D (2012) Novel minidystrophin gene dual adeno-associated virus vectors restore neuronal nitric oxide synthase expression at the sarcolemma. Hum Gene Ther 23(1):98–103
34. Allocca M et al (2008) Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice. J Clin Invest 118(5):1955–1964
35. Hermonat PL et al (1997) The packaging capacity of adeno-associated virus (AAV) and the potential for wild-type-plus AAV gene therapy vectors. FEBS Lett 407(1):78–84
36. Grieger JC, Samulski RJ (2005) Adenoassociated virus as a gene therapy vector: vector development, production and clinical applications. Adv Biochem Eng Biotechnol 99: 119–145
37. Wu J et al (2007) Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity. Hum Gene Ther 18(2):171–182
38. Grose WE et al (2012) Homologous recombination mediates functional recovery of Dysferlin defi ciency following AAV5 gene transfer. PLoS One 7(6), e39233
39. Grieger JC, Choi VW, Samulski RJ (2006) Production and characterization of adenoassociated viral vectors. Nat Protoc 1(3): 1412–1428
40. Hirsch ML, Samulski RJ (2014) AAV-mediated gene editing via double-strand break repair. Methods Mol Biol 1114:291–307
41. Lock M et al (2010) Rapid, simple, and versatile manufacturing of recombinant adenoassociated viral vectors at scale. Hum Gene Ther 21(10):1259–1271